bearish
Last Week in GER Research: Ascletis Pharma, China Tower, Pinduoduo, Beigene and CNFinance
810 Views06 Aug 2018 04:50
Below is a recap of the key IPO research produced by the Global Equity Research team. This week we highlight our sensitivity analysis for Ascletis...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- IPO Trading Strategy: From Pop to Flop? A Deep-Dive on HK IPO Performance20 Sep 2018
- Last Week in GER Research: Meituan, Nio, Haidilao, Shandong Gold, China Renais., X Financial and PDD17 Sep 2018
- Last Week in GER Research: Meituan, China Tower, Haidilao, Qutoutiao, Hua Med., Chunlai, and Cootek10 Sep 2018
- Pinduoduo (PDD US): Keep Calm and Ride the Storm01 Aug 2018
- Last Week in GER Research: Pindoudou, China Tower, Cango, Amazon, Aurora, Hope Ed., Ascletis and STX30 Jul 2018
- China Tower IPO Preview: Feeble Safeguards for Minority Shareholders25 Jun 2018
x